5 Einträge gefunden

1. First-line immune-checkpoint inhibitor combination therapy for chemotherapy-eligible patients with metastatic urothelial carcinoma: A systematic review and meta-analysis

   1. Mori, Keiichiro
   2. Pradere, Benjamin
   3. Moschini, Marco
   4. Mostafaei, Hadi
   5. Laukhtina, Ekaterina
   6. Schuettfort, Victor M
   7. Sari Motlagh, Reza

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis

   1. Mori, Keiichiro
   2. Pradere, Benjamin
   3. Quhal, Fahad
   4. Katayama, Satoshi
   5. Mostafaei, Hadi
   6. Laukhtina, Ekaterina
   7. Schuettfort, Victor M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Differential prognostic impact of different Gleason patterns in grade group 4 in radical prostatectomy specimens

   1. Mori, Keiichiro
   2. Sharma, Vidit
   3. Comperat, Eva M
   4. Sato, Shun
   5. Laukhtina, Ekaterina
   6. Schuettfort, Victor M
   7. Pradere, Benjamin

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
4. First-line Immunotherapy-based Combinations for Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis

   1. Quhal, Fahad
   2. Mori, Keiichiro
   3. Bruchbacher, Andreas
   4. Resch, Irene
   5. Mostafaei, Hadi
   6. Pradere, Benjamin
   7. Schuettfort, Victor M

   2021 - Forschungsinformationssystem des UKE
5. Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis

   1. Mori, Keiichiro
   2. Mostafaei, Hadi
   3. Pradere, Benjamin
   4. Motlagh, Reza Sari
   5. Quhal, Fahad
   6. Laukhtina, Ekaterina
   7. Schuettfort, Victor M

   2020 - Forschungsinformationssystem des UKE